Toxicological profiling of nutraceutical-grade curcumin-loaded solid lipid nanoparticles using Caco-2 cells and zebrafish (Danio rerio) embryo models

Read full text
Authors: Raquel F.S. Gonçalves, Joana Ribeiro, Joana T. Martins, Marisa Sárria Pereira de Passos, Andreia Castro Gomes, António Augusto Vicente, Ana Cristina Pinheiro
Cited by: 1
References: 29

Abstract

The development of bio-based nanostructures to encapsulate bioactive compounds represents a promising approach for creating functional foods with improved nutritional and health benefits. However, their regular dietary use raises safety concerns, even when using food-grade ingredients. This study aimed to evaluate the toxicity of curcumin-loaded solid lipid nanoparticles (SLN_curc) through in vitro assays with Caco-2 cells and in vivo assays with zebrafish embryos ( Danio rerio ). In vitro , free curcumin reduced Caco-2 viability to slightly below 80% across all (nominal) tested concentrations, while both SLN and SLN_curc maintained cell viability above 80%, suggesting no cytotoxicity. In vivo , free curcumin and SLN_curc caused high mortality at the highest (nominal) concentrations, and SLN alone induced over 75% lethality at 50 μg·mL −1 , indicating that curcumin itself strongly contributes to acute toxicity above 5 μg·mL −1 . Nonetheless, SLN and SLN_curc produced significant concentration-dependent effects on most sub-lethal parameters, though SLN_curc exhibited no significant sub-lethal toxicity at (nominal) concentrations below 5 μg·mL −1 . Overall, curcumin-loaded SLNs demonstrated a safe profile at lower (nominal) concentrations, supporting their potential in functional foods and supplements. Moreover, zebrafish embryos proved to be a valuable alternative vertebrate model for high-throughput screening of nanostructures in food applications.

Fields of Study & Subjects

Curcumin's Biomedical Applications Advancements in Transdermal Drug Delivery Melamine detection and toxicity

Publication details

Journal / source
Toxicology in Vitro
Publisher
Elsevier BV
Volume
113
Pages
106215–106215
Publication date
18 February 2026
Language
EN